Analyst Ratings for 89bio
Portfolio Pulse from Benzinga Insights
89bio (NASDAQ:ETNB) has received 5 bullish analyst ratings in the last quarter, with an average price target of $38.8, implying significant upside from the current price of $16.22. The average price target has increased by 11.91% over the past month.
August 10, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
89bio has received 5 bullish analyst ratings in the last quarter, with an average price target of $38.8, indicating a potential upside from the current price of $16.22.
The bullish analyst ratings and the significant increase in the average price target over the past month suggest a positive outlook for 89bio. This could potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100